Lumiphore

Lumiphore, a biotechnology company based in Berkeley, California, specializes in next-generation chelation technology for radiotheranostics, leveraging its proprietary macrocyclic BiFunctional Chelate (mBFC) to develop innovative diagnostic and therapeutic constructs aimed at improving human health. Founded in 2001 as a spin-out from Dr. Kenneth Raymond's laboratory at the University of California, Berkeley, the company harnesses extensive expertise in metal chelation to create high-stability radiopharmaceuticals suitable for both imaging and therapeutic applications.

With a strong focus on advancing cancer targeting agents, Lumiphore's technology enables rapid, room-temperature chelation of a variety of radionuclides, ensuring high versatility and fidelity of targeting agents. The company is actively collaborating with partners to explore novel targeted radiotheranostics and enhance drug discovery through its sensitive Mix-and-Read diagnostics platform, which features exceptional brightness and stability.

Generated from the website